Graham Capital Management L.P. Takes Position in Ardent Health, Inc. $ARDT

Key Points

• Graham Capital Management L.P. acquired a new stake in Ardent Health, Inc., purchasing 43,498 shares valued at approximately $598,000 in the first quarter.
• Vanguard Group Inc. significantly increased its stake by 368.9%, owning 1,330,635 shares worth $18,296,000 following the acquisition of over a million additional shares.
• Ardent Health's stock is currently trading at $13.19, and the company recently reported earnings of $0.52 per share, surpassing analysts' expectations.

Graham Capital Management L.P. purchased a new position in shares of Ardent Health, Inc. (NYSE:ARDT - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 43,498 shares of the company's stock, valued at approximately $598,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Point72 Asia Singapore Pte. Ltd. bought a new position in Ardent Health during the 4th quarter worth approximately $27,000. Morse Asset Management Inc bought a new position in Ardent Health during the 1st quarter worth approximately $36,000. Deutsche Bank AG raised its holdings in Ardent Health by 1,251.9% during the 4th quarter. Deutsche Bank AG now owns 2,866 shares of the company's stock worth $49,000 after purchasing an additional 2,654 shares during the last quarter. Quarry LP grew its position in shares of Ardent Health by 1,519.4% during the 1st quarter. Quarry LP now owns 5,020 shares of the company's stock worth $69,000 after buying an additional 4,710 shares during the period. Finally, Y Intercept Hong Kong Ltd acquired a new stake in shares of Ardent Health during the 1st quarter worth approximately $142,000.

Analyst Ratings Changes

ARDT has been the subject of several recent analyst reports. KeyCorp reduced their price objective on shares of Ardent Health from $24.00 to $20.00 and set an "overweight" rating for the company in a research report on Thursday, August 7th. UBS Group started coverage on shares of Ardent Health in a research report on Wednesday. They set a "buy" rating and a $17.00 price objective for the company. Royal Bank Of Canada reissued an "outperform" rating and issued a $21.00 price target on shares of Ardent Health in a research report on Thursday, May 15th. Bank of America downgraded shares of Ardent Health from a "neutral" rating to an "underperform" rating and reduced their price target for the company from $15.50 to $14.60 in a research report on Wednesday, July 16th. Finally, JPMorgan Chase & Co. reduced their price target on shares of Ardent Health from $18.00 to $15.00 and set a "neutral" rating for the company in a research report on Monday, August 11th. Nine equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $19.33.

Ardent Health Stock Up 1.5%

ARDT traded up $0.19 during mid-day trading on Thursday, reaching $13.22. 58,439 shares of the stock were exchanged, compared to its average volume of 391,997. The company has a debt-to-equity ratio of 0.66, a quick ratio of 2.00 and a current ratio of 2.13. The stock has a market capitalization of $1.89 billion, a PE ratio of 7.31, a price-to-earnings-growth ratio of 5.96 and a beta of 0.30. The company has a 50 day moving average price of $12.32 and a two-hundred day moving average price of $13.15. Ardent Health, Inc. has a 1 year low of $10.10 and a 1 year high of $20.72.

Ardent Health (NYSE:ARDT - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.30 by $0.22. The firm had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.54 billion. Ardent Health had a net margin of 4.11% and a return on equity of 16.66%. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. As a group, research analysts anticipate that Ardent Health, Inc. will post 1.23 EPS for the current year.

Ardent Health Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.